Broad Institute

MAY 30, 2024

Introduction to Pharmacogenetics By Rose Circeo May 30, 2024 Breadcrumb Home Introduction to Pharmacogenetics The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease. Several talks each year focus on bioethical considerations in genomics research.

Pharmacogenetics 52

Pharmacogenetics Bioethics Disease Research 52

Broad Institute

MAY 9, 2024

Genomic Interpretation, seqr and Matchmaker Exchange By Rose Circeo May 9, 2024 Breadcrumb Home Genomic Interpretation, seqr and Matchmaker Exchange The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

APRIL 25, 2024

Structural Variation in Human Genomes By Rose Circeo April 25, 2024 Breadcrumb Home Structural Variation in Human Genomes The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease. Several talks each year focus on bioethical considerations in genomics research.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

APRIL 11, 2024

Understand Single Cell ATAC-Seq Data Analysis By Rose Circeo April 11, 2024 Breadcrumb Home Understand Single Cell ATAC-Seq Data Analysis The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

MARCH 22, 2024

Rare Variant Interpretation By Rose Circeo March 22, 2024 Breadcrumb Home Rare Variant Interpretation The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease. Several talks each year focus on bioethical considerations in genomics research.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

APRIL 4, 2024

A Practical guide to bulk RNA-seq, including guidelines for eQTL analysis By Rose Circeo April 4, 2024 Breadcrumb Home A Practical guide to bulk RNA-seq, including guidelines for eQTL analysis The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

RNA 52

RNA Bioethics Disease Research 52

Agency IQ

MARCH 29, 2024

regulatory framework Webinar/ Seminar ( OPEN ) EMA 4/17/2024 4/17/2024 CEP 2.0: regulatory framework Webinar/ Seminar ( OPEN ) EMA 4/17/2024 4/17/2024 CEP 2.0: regulatory framework Webinar/ Seminar ( OPEN ) EMA 4/17/2024 4/17/2024 CEP 2.0: regulatory framework Webinar/ Seminar ( OPEN ) EMA 4/17/2024 4/17/2024 CEP 2.0:

Regulations 40

Regulations Production Biosimilars Clinical Trials 40

Broad Institute

FEBRUARY 8, 2024

Integration of GWAS and functional data By Rose Circeo February 8, 2024 Breadcrumb Home Integration of GWAS and functional data The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

FEBRUARY 1, 2024

A brief history of non-invasive prenatal testing By Rose Circeo February 1, 2024 Breadcrumb Home A brief history of non-invasive prenatal testing The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

JANUARY 18, 2024

MPG Primer: All of Us Primer, Part 2 By Rose Circeo January 18, 2024 Breadcrumb Home MPG Primer: All of Us Primer, Part 2 The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease. Several talks each year focus on bioethical considerations in genomics research.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

JANUARY 11, 2024

MPG Primer: All of Us Primer, Part 1 By Rose Circeo January 11, 2024 Breadcrumb Home MPG Primer: All of Us Primer, Part 1 The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease. Several talks each year focus on bioethical considerations in genomics research.

Bioethics 52

Bioethics Disease Research 52

Drug Discovery World

OCTOBER 18, 2023

Sara Donnelly, Director of Research Planning and Business Development at PhoenixBio USA explores why the right pre-clinical model is essential for teams wanting to advance adeno-associated virus vector-based gene therapies. Adeno-associated virus (AAV) vector-based gene therapies hold exceptional promise across a range of disease areas.

Therapies 162

Therapies Clinical Trials FDA Approval Virus 162

Broad Institute

DECEMBER 7, 2023

MPG Primer: Basics of gene editing/CRISPR By Rose Circeo December 7, 2023 Breadcrumb Home MPG Primer: Basics of gene editing/CRISPR The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Agency IQ

MARCH 1, 2024

Start Date End Date Event Event Type Organization 2/28/2024 2/28/2024 Workshop on Medical Radioisotopes Conference ( CLOSED ) Belgian Council Presidency 2/28/2024 2/28/2024 The path to diagnosis – the challenge of rare diseases Webinar/ Seminar ( OPEN ) Martin Zeitz Center for Rare Diseases at the University Hospital Hamburg-Eppendorf 2/28/2024 (..)

Regulations 40

Regulations Biosimilars Clinical Trials Production 40

Broad Institute

OCTOBER 19, 2023

MPG Primer: Introduction to fine-mapping By Rose Circeo October 19, 2023 Breadcrumb Home MPG Primer: Introduction to fine-mapping The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

NOVEMBER 30, 2023

Experts from across the Medical and Population Genetics community at the Broad Institute give in-depth introductions to research in human genetics through overviews of core concepts and practical tutorials on tools for biostatistics, computational genomics, and variant annotation.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

OCTOBER 12, 2023

MPG Primer: Modeling rare variation and calculating genetic constraint By Rose Circeo October 12, 2023 Breadcrumb Home MPG Primer: Modeling rare variation and calculating genetic constraint The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

SEPTEMBER 28, 2023

Mono- and bi-valent allele impact By Rose Circeo September 28, 2023 Breadcrumb Home Mono- and bi-valent allele impact The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease. Several talks each year focus on bioethical considerations in genomics research.

Bioethics 52

Bioethics Disease Research 52

KIF1A

MAY 4, 2024

Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. In this week’s article, researchers in Brazil identified a KIF1A mutation in a cohort of patients with congenital ataxia.

Science 116

Science Medical Schools RNA Research 116

Agency IQ

OCTOBER 27, 2023

Upcoming Webinar Hosted by Xtalks Webinar/Seminar ( OPEN) Xtalks 11/6/2023 11/6/2023 What is the evidence for high-risk medical devices in the field of cardiovascular disease and diabetes?

Regulations 40

Regulations Pharmaceuticals Production Packaging 40

Agency IQ

MAY 31, 2024

Start Date End Date Event Event Type Organization 6/03/2024 6/03/2024 Product Management Service (PMS) Product UI and API training (access & navigation) Webinar/Seminar ( OPEN ) EMA 6/03/2024 6/07/2024 Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the E.U.:

Regulations 40

Regulations Production Compliance Pharmaceuticals 40

Broad Institute

JUNE 21, 2023

Harmonization of deeply sequenced genomes By admin June 21, 2023 Breadcrumb Home Harmonization of deeply sequenced genomes The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease. Several talks each year focus on bioethical considerations in genomics research.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

JUNE 1, 2023

Mostly natural sequencing-by-synthesis for scRNA-seq using Ultima sequencing By Rose Circeo June 1, 2023 Breadcrumb Home Mostly natural sequencing-by-synthesis for scRNA-seq using Ultima sequencing The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

KIF1A

MARCH 9, 2024

Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. Ltd and was engaged in research related to the extraction and culture of stem cells and immune cells. Meet our Guest Bloggers! Having graduated from the B.S.

Laboratories 111

Laboratories Science Research Disease 111

Agency IQ

AUGUST 2, 2024

For example, on July 25, the Hungarian presidency hosted an informal meeting of health ministers to discuss health issues, such as mitigating the effect of cardiovascular diseases and implementing the European Health Data Space (EHDS).

Regulations 40

Regulations Clinical Trials Production International 40

The Pharma Data

OCTOBER 14, 2020

Each year, more than 700 000 people die from vector-borne diseases (VBDs) such as malaria, dengue, schistosomiasis, leishmaniasis, Chagas disease, yellow fever and Japanese encephalitis, among others. Taken together, these diseases exact an immense toll on economies and can impede both rural and urban development. New guidance.

Government 52

Government Disease Research 52

Drug Target Review

MAY 31, 2024

Could you share an example of a specific project or research that you have worked on and the impact it has had in your field? How has your research in STEM contributed to advancements or improvements in your field, and what potential future applications or implications do you foresee based on your work?

Organic Chemistry 45

Organic Chemistry Computational Chemistry Small Molecule Disease 45

Drug Discovery World

OCTOBER 13, 2022

There were 127 exhibitors, 180 posters, 40 technology speakers, 52 scientific speakers as well as a series of eight seminars focused on automation and technology which DDW organised and moderated in the dedicated Tech Theatre. . Over the two days at ExCel, 1554 delegates attended the event. Of those delegates, 75% work in drug discovery.

Drugs 130

Drugs Cell Based Assays Science Assay Development 130

Agency IQ

JULY 8, 2024

For delegated acts, the co-legislators usually have two months to object to the proposals but cannot amend them. For implementing acts, the Commission is required to consult with a committee before adoption.

Regulations 40

Regulations Pharmaceuticals Production Compliance 40

Practical Cheminformatics

DECEMBER 7, 2023

In these cases, broadening your skillset into other areas like medicinal chemistry, pharmacology, biophysics, pharmacokinetics, and disease biology is important. The Medicinal Chemistry Gordon Research Seminar ( GRS ) provides a condensed version of ResMed. There are many ways to broaden your skills. Ask a lot of questions.

Computational Chemistry 90

Computational Chemistry Pharmacokinetics Pharmaceutical Companies Drugs 90

Agency IQ

MAY 3, 2024

Start Date End Date Event Event Type Organization 4/30/2024 4/30/2024 Seminar No. Start Date End Date Event Event Type Organization 4/30/2024 4/30/2024 Seminar No. Start Date End Date Event Event Type Organization 4/30/2024 4/30/2024 Seminar No. Start Date End Date Event Event Type Organization 4/30/2024 4/30/2024 Seminar No.

Regulations 40

Regulations Clinical Trials Production Biosimilars 40

Drug Discovery World

AUGUST 16, 2022

These observations may come to light in the clinic, but these disparities can be attributed to every phase of the drug development pipeline – clinical trials, translational research and, ultimately, drug discovery. . Moreover, the environmental conditions of a locality directly influence the health outcomes of its residents.

Research 130

Research Clinical Trials Trials Drug Development 130

Agency IQ

AUGUST 23, 2024

Introducing Lias for a plenary at the event, Gutierrez said: “Courtney is in the paperwork for the seminar, she’s put down as the Acting Director. The pilot was only open to certain drug sponsors with oncology products regulated by the Center for Drug Evaluation and Research (CDER).

FDA 40

FDA Laboratories Regulations Clinical Trials 40

Agency IQ

OCTOBER 6, 2023

BY AMANDA CONTI | OCT 4, 2023 10:40 PM CDT A quick note: How AgencyIQ gathers data on drug approvals AgencyIQ reviews drug approvals from the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER). Featuring previous research by Kedest Tadesse, Kari Oakes and Alec Gaffney.

FDA 52

FDA Biosimilars Science Production 52

Agency IQ

DECEMBER 1, 2023

and Annex 1 Conference Joel Welch December 12 AgencyIQ Looking ahead to 2024: Regulatory Forecast for the U.S. and Annex 1 Conference Joel Welch December 12 AgencyIQ Looking ahead to 2024: Regulatory Forecast for the U.S. ” The report will also cover Federal agency roles in addressing vulnerabilities and statutory limitations.

FDA 40

FDA Science Regulations Production 40